NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

flipper44,

Dr. Linda Liau explained last year how to make DCVax-L more effective for ALL patients. Her understanding most assuradly has been passed on to all doctors involved in this study. Maybe that is why she mentioned not reaching a preset number of events since they are now comparing early treatment vs crossover treatment. If you can't end the trial because secondary events are not happening as expected then that is not good for the trial but it is really good for the patients. The unfortunate part of this study is that treatment stops after 3 years and those who might otherwise have benefitted greatly were left to event without treatment if they were long surviving SOC patients. This is what appears to have happened with Rkmatters nephew. I give her the highest praise for sticking this out through thick and thin in the hopes of seeing this work.